We tackle issues that matter to doctors

Ep. 97 Evidence-Based Economics: What the Doctor Ordered?

Peter G. Klein, PhD

Will the randomized control trial bring more clarity and certainty to economic science?  Is “evidence-based economics” something to be hailed as a welcome innovation or should it be appraised with a more sober attitude?  To examine this topic and discuss the relative place of randomized trials in economics and medicine we have as our guest Peter G. Klein,  W. W. Caruth Chair and Professor of Entrepreneurship at Baylor University’s Hankamer School of Business.  Professor Klein is also the Carl Menger Research Fellow at the Ludwig von Mises Institute.  He obtained his PhD in Economics from the University of California Berkeley, and his BA from the University of North Carolina Chapel Hill.

His field of interest is in the area of the economics of entrepreneurship and business organization.  He taught previously at the University of California, Berkeley, the University of Georgia, the Copenhagen Business School, and the University of Missouri, and served as a Senior Economist with the Council of Economic Advisers.  He is the author of 5 books and numerous peer-reviewed articles.

GUEST:

Peter G. Klein:  Twitter and academic web page

LINKS:

Klein, P. “New Nobel Winners Are Latest Bad Science for Economic Theory” (Article on the Ludwig von Mises Institute website).

RELATED EPISODE:

Ep. 30 Beyond EBM: Case-Based Reasoning and the Integration of Clinical Knowledge (with guest Mark Tonelli, MD)

SUPPORT THE SHOW:

Make a small donation on our Patreon page and join our discussion group or receive a free book.

WATCH THE SHOW:

View the episode on our YouTube Channel

2 Comments

  1. Anthony Perry, MD on 11/10/2019 at 12:58 AM

    Great discussion.

    • Michel Accad on 11/10/2019 at 1:16 AM

      Thanks!

Leave a Comment